Skip to main content

LYMPHANGITIC CARCINOMATOSIS

Tracking # 20-1063632

$99999.00

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

LYMPHANGITIC CARCINOMATOSIS IS THE INFILTRATION AND INFLAMMATION OF LYMPHATIC VESSELS SECONDARY TO THE SPREAD OF MALIGNANCY FROM A PRIMARY SITE. PULMONARY LYMPHANGITIC CARCINOMATOSIS ALMOST ALWAYS REPRESENTS THE CLINICAL FORM OF LYMPHANGITIC CARCINOMATOSIS AND DENOTES AN END-STAGE MALIGNANCY WITH POOR PROGNOSIS. THIS ACTIVITY COVERS THE ETIOLOGY, CLINICAL FEATURES, DIAGNOSTIC EVALUATION AND MANAGEMENT OF SUSPECTED PULMONARY LYMPHANGITIC CARCINOMATOSIS AND HIGHLIGHTS THE ROLE OF THE INTERPROFESSIONAL TEAM IN DELIVERING THE BEST OUTCOME IN A GIVEN PATIENT.

Subject areas

This course counts toward the state boards and subject areas below.

Bahamas Medical Council

Specialty Medical Practitioner

1.5h General Medicine

Louisiana State Board of Medical Examiners - Physicians & Surgeons

Physician & Surgeon

1.5h Category I CME

Mississippi State Board of Medical Licensure

Medical Doctor

1.5h AMA Category I

Physician Assistant

1.5h AMA Category I

State Medical Board of Ohio

Doctor of Medicine

1.5h AMA Category I